{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:25:11Z","timestamp":1784168711745,"version":"3.55.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260656-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Magnetic resonance imaging (MRI) is increasingly used for local staging in prostate cancer, yet its value relative to digital rectal examination (DRE) staging remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260656-5\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare the performance of MRI-based vs DRE-based clinical T staging in men undergoing radical prostatectomy (RP) and to assess the outcome of substituting MRI staging in established prognostic classification systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260656-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter, retrospective case-control study (iTNM Consortium) was conducted from January 1, 2015, to December 31, 2021, among consecutive men 18 years or older with clinically localized or locally advanced prostate cancer who underwent RP and preoperative multiparametric MRI and systematic biopsies with or without targeted biopsies at 31 referral centers across 6 European countries. Patients receiving prior prostate cancer treatment or missing key variables were excluded. Data analysis was performed from August to October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260656-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>MRI-derived T stage (iT) vs DRE-derived T stage (cT) incorporated into D\u2019Amico, European Association of Urology, National Comprehensive Cancer Network, and International Staging Collaboration for Prostate Cancer risk groups to generate MRI-adapted classification systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260656-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary outcome was distant metastasis\u2013free survival. Secondary outcomes were biochemical recurrence\u2013free survival and overall survival. Discrimination was assessed using a C index and time-dependent area under the receiver operating characteristic curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260656-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 4425 men were included (median [IQR] age, 66 [61-70] years; median [IQR] prostate-specific antigen, 7.4 [5.5-10.5] ng\/mL). Median (95% CI) follow-up was 52 (51-53) months. MRI-based staging showed slightly higher discriminatory ability than DRE staging for biochemical recurrence\u2013free survival (C index, 0.62 [95% CI, 0.61-0.64] vs 0.59 [95% CI, 0.57-0.61]) and distant metastasis\u2013free survival (0.67 [95% CI, 0.64-0.70] vs 0.65 [95% CI, 0.62-0.68]). However, across all 4 risk classification systems, MRI-based and DRE-based versions demonstrated comparable discrimination with overlapping 95% CIs. Time-dependent area under the receiver operating characteristic curves showed no significant difference during follow-up. Subgroup analyses of patients with cT1 disease and those with PSA levels less than 10 ng\/mL yielded similar results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260656-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this case-control study of patients undergoing radical prostatectomy, MRI-based staging demonstrated discrimination similar to traditional DRE-based staging for biochemical recurrence, distant metastasis, and overall survival. These findings suggested that MRI-derived staging could be safely integrated into contemporary risk systems without compromising accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.23288","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:00:35Z","timestamp":1784127635000},"page":"e2623288","source":"Crossref","is-referenced-by-count":1,"title":["Performance of MRI-Based vs Clinical T Staging in Localized Prostate Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Arthur","family":"Peyrottes","sequence":"first","affiliation":[{"name":"Department of Urology, H\u00f4pital Saint-Louis, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[{"name":"Department of Urology, North Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille, Aix Marseille University, French National Centre for Scientific Research, Interdisciplinary Nanoscience Center of Marseille, ERL INSERM U 1326, European Center for Research in Medical Imaging, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Long-Depaquit","sequence":"additional","affiliation":[{"name":"Department of Urology, North Hospital, Assistance Publique\u2013H\u00f4pitaux de Marseille, Aix Marseille University, French National Centre for Scientific Research, Interdisciplinary Nanoscience Center of Marseille, ERL INSERM U 1326, European Center for Research in Medical Imaging, Marseille, France"},{"name":"Department of Urology, Saint-Anne Instruction Hospital, Service de Sant\u00e9 des Arm\u00e9es, Toulon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[{"name":"Groupe Recherche Clinique 5 Predictive Onco-Urology, Assistance Publique\u2013H\u00f4pitaux de Paris, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Roumeguere","sequence":"additional","affiliation":[{"name":"Department of Urology, Jules Bordet Institute-Erasme Hospital, Brussels University Hospital, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Peltier","sequence":"additional","affiliation":[{"name":"Department of Urology, Jules Bordet Institute-Erasme Hospital, Brussels University Hospital, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[{"name":"Department of Urology, La Croix du Sud H\u00f4pital, Quint Fonsegrives, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Diamand","sequence":"additional","affiliation":[{"name":"Department of Urology, Jules Bordet Institute-Erasme Hospital, Brussels University Hospital, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"iTNM Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Anract","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Assenmacher","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Barret","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Beatrici","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Benamran","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Benard","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Bergier","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Bollen","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Brancelli","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"de Brek","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brureau","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chicaud","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Coscarella","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dariane","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Diamand","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Duquesne","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaconsiglia","family":"Ferriero","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Fiard","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Giesen","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"De Groote","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Himmelsbach","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Holz","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Jourdan","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Lefranc","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phan","family":"L\u00e9vy","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Long Depaquit","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mazeaud","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Mesnard","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Moretto","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myky","family":"Nguyen","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Oderda","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Olivier","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Paillusson","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Panthier","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Pattou","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Peyrottes","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"R\u00f8der","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Sanson-Stern","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sasia","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August","family":"Sigle","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein Vincent","family":"Stroomberg","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayek","family":"Taha","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Tissot","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Van Damme","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Waeckel","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Windisch","sequence":"additional","affiliation":[{"name":"for the iTNM Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"6 Pt 1","key":"zoi260656r1","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/S0022-5347(01)62251-1","article-title":"The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.","volume":"160","author":"D\u2019Amico","year":"1998","journal-title":"J Urol"},{"issue":"6","key":"zoi260656r2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.eururo.2013.03.033","article-title":"A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.","volume":"64","author":"Zumsteg","year":"2013","journal-title":"Eur Urol"},{"key":"zoi260656r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u20142024 Update, part I: screening, diagnosis, and local treatment with curative intent.","author":"Cornford","journal-title":"Eur Urol"},{"key":"zoi260656r4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050","article-title":"NCCN Clinical Practice Guidelines in Oncology - Prostate Cancer. Version 1.","author":"Schaeffer","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"zoi260656r5","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","article-title":"Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the International Staging Collaboration for Cancer of the Prostate.","volume":"6","author":"Dess","year":"2020","journal-title":"JAMA Oncol"},{"issue":"6","key":"zoi260656r6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.euo.2023.09.008","article-title":"Digital rectal examination is not a useful screening test for prostate cancer.","volume":"6","author":"Krilaviciute","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"zoi260656r7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.euo.2023.12.005","article-title":"Comparing the performance of digital rectal examination and prostate-specific antigen as a screening test for prostate cancer: a systematic review and meta-analysis.","volume":"7","author":"Matsukawa","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"10","key":"zoi260656r9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5489\/cuaj.9164","article-title":"Does the digital rectal exam still provide value in the age of MRI?","volume":"19","author":"Albers","year":"2025","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"zoi260656r10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO Guideline, part i: introduction, risk assessment, staging, and risk-based management.","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"12","key":"zoi260656r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2024.102717","article-title":"French AFU Cancer Committee Guidelines - update 2024-2026: prostate cancer - diagnosis and management of localised disease.","volume":"34","author":"Ploussard","year":"2024","journal-title":"Fr J Urol"},{"key":"zoi260656r12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urology.2019.04.023","article-title":"Impact of magnetic resonance imaging on prostate cancer staging and European Association of Urology risk classification.","volume":"130","author":"Draulans","year":"2019","journal-title":"Urology"},{"issue":"1","key":"zoi260656r13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1186\/s12885-022-09955-w","article-title":"Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population.","volume":"22","author":"Lophatananon","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"zoi260656r14","doi-asserted-by":"publisher","first-page":"106.e9","DOI":"10.1016\/j.urolonc.2022.10.023","article-title":"The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: a Will Rogers phenomenon.","volume":"41","author":"Rakauskas","year":"2023","journal-title":"Urol Oncol"},{"key":"zoi260656r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.09.005","article-title":"Magnetic resonance imaging\u2013based t-staging to predict biochemical recurrence after radical prostatectomy: a step towards the iTNM classification.","author":"Baboudjian","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"zoi260656r16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2.","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"zoi260656r19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eururo.2021.07.027","article-title":"Risk stratification of patients candidate to radical prostatectomy based on clinical and multiparametric magnetic resonance imaging parameters: development and external validation of novel risk groups.","volume":"81","author":"Mazzone","year":"2022","journal-title":"Eur Urol"},{"issue":"4","key":"zoi260656r20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time.","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"10","key":"zoi260656r21","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"issue":"2","key":"zoi260656r22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis.","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol"},{"key":"zoi260656r23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.urology.2020.08.089","article-title":"Multiparametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification.","volume":"147","author":"Soeterik","year":"2021","journal-title":"Urology"},{"issue":"1","key":"zoi260656r24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.juro.2007.08.125","article-title":"The Will Rogers phenomenon in urological oncology.","volume":"179","author":"Gofrit","year":"2008","journal-title":"J Urol"},{"key":"zoi260656r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.09.017","article-title":"Molecular correlates of prostate cancer visibility on multiparametric magnetic resonance imaging: a systematic review.","author":"Fazekas","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"zoi260656r26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1470-2045(20)30730-0","article-title":"Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.","volume":"22","author":"Gharzai","year":"2021","journal-title":"Lancet Oncol"},{"key":"zoi260656r18","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2016","edition":"8th ed"},{"key":"zoi260656r8","unstructured":"British Association of Urological Surgeons. Rectal Exam a \u201cPoor Test for Prostate Cancer\u201d \u2014 Surgeons and Charity Agree. Accessed May 26, 2026. https:\/\/www.baus.org.uk\/professionals\/baus_business\/news\/289\/rectal_exam_a_poor_test_for_prostate_cancer_surgeons_and_charity_agree\/"},{"key":"zoi260656r17","unstructured":"American College of Radiology, European Section of Uro-Radiology. PI-RADS\u00ae: Prostate Imaging \u2013 Reporting and Data System v2.1. Published online 2019. Accessed October 1, 2025. https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/PI-RADS\/PIRADS-2019.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851648\/peyrottes_2026_oi_260656_1783527866.46776.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:00:36Z","timestamp":1784127636000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.23288","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}